Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C37H37F2N3O4S |
| Molecular Weight | 657.769 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OC(=O)C1=CN(CC2=C(F)C=CC=C2F)C3=C(C(CN(C)CC4=CC=CC=C4)=C(S3)C5=CC=C(NC(=O)C(C)C)C=C5)C1=O
InChI
InChIKey=RANJJVIMTOIWIN-UHFFFAOYSA-N
InChI=1S/C37H37F2N3O4S/c1-22(2)35(44)40-26-16-14-25(15-17-26)34-28(19-41(5)18-24-10-7-6-8-11-24)32-33(43)29(37(45)46-23(3)4)21-42(36(32)47-34)20-27-30(38)12-9-13-31(27)39/h6-17,21-23H,18-20H2,1-5H3,(H,40,44)
| Molecular Formula | C37H37F2N3O4S |
| Molecular Weight | 657.769 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/9784092Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/16789738
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9784092
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/16789738
T-98475 is a non-peptide gonadotropin-releasing hormone receptor antagonist. Upon oral administration, T-98475 was able to suppress suppression of plasma LH concentrations in castrated male cynomolgus monkeys. However, the in vivo antagonism of T-98475 when administered orally was not as effective as was expected, and development of compound was discontinued in favor of more advanced drug candidates.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9784092
Curator's Comment: # Takeda Chemical Industries
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1855 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9784092 |
0.2 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9784092
Upon oral administration at 60 mg/kg, T-98475 was able to suppress suppression of plasma LH concentrations in castrated male cynomolgus monkeys.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9784092
Labeled leuprorelin (0.15 nM) and the membrane fractions (0.2 mg/mL) of CHO cells expressing the human LHRH receptor were incubated at 25 °C for 60 min in 0.2 mL of assay buffer in the presence of various concentrations of test compound. The reaction was terminated by the addition of 2 mL of ice-cold assay buffer, and bound and free ligands were separated by filtration through a poly(ethylenimine)-coated glass microfiber filter. The filter was washed twice with 2 mL of assay buffer, and radioactivity was measured using a gamma-ray counter. Specific binding was determined by subtraction of the non-specific binding, which was measured in the presence of 1 uM unlabeled leuprorelin. T-98475 displaced leuprorelin with IC50 of 0.2 nM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:48:38 GMT 2025
by
admin
on
Mon Mar 31 18:48:38 GMT 2025
|
| Record UNII |
F1KLT23O3A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9874838
Created by
admin on Mon Mar 31 18:48:38 GMT 2025 , Edited by admin on Mon Mar 31 18:48:38 GMT 2025
|
PRIMARY | |||
|
F1KLT23O3A
Created by
admin on Mon Mar 31 18:48:38 GMT 2025 , Edited by admin on Mon Mar 31 18:48:38 GMT 2025
|
PRIMARY | |||
|
192887-28-8
Created by
admin on Mon Mar 31 18:48:38 GMT 2025 , Edited by admin on Mon Mar 31 18:48:38 GMT 2025
|
PRIMARY | |||
|
DTXSID90432134
Created by
admin on Mon Mar 31 18:48:38 GMT 2025 , Edited by admin on Mon Mar 31 18:48:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |